4//SEC Filing
NUPATHE INC. 4
Accession 0001209191-14-013761
CIK 0001375200operating
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 11:00 AM ET
Size
8.9 KB
Accession
0001209191-14-013761
Insider Transaction Report
Form 4
NUPATHE INC.PATH
Datin James A
Director
Transactions
- Disposition from Tender
Common Stock
2014-02-21$6.80/sh−20,620$140,216→ 0 total
Footnotes (1)
- [F1]Disposed upon the consummation of the merger contemplated by the Agreement and Plan of Merger, dated January 17, 2014, among the issuer, Teva Pharmaceutical Industries Ltd. and Train Merger Sub, Inc., in exchange for $3.65 per share, plus contractual rights to receive up to an additional $3.15 in contingent cash consideration payments per share.
Issuer
NUPATHE INC.
CIK 0001375200
Entity typeoperating
Related Parties
1- filerCIK 0001375200
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 11:00 AM ET
- Size
- 8.9 KB